askapharm

Pharmacy Approaches for Administering Effective Treatment Using Antibody Platforms

Multiple myeloma, a cancer of plasma cells, has seen significant advancements in treatment options over recent years. One of the most promising developments has been the use of antibody therapies, particularly CD38 antibodies and bispecific antibodies. As healthcare providers integrate these therapies into their practice, it is essential to stay informed about the latest advances and best practices in managing patients with multiple myeloma.

Pharmacy Approaches for Administering Effective Treatment Using Antibody Platforms Read More »

Transition of OneTouch Verio Reflect® Meter to Over the Counter Purchases

Starting September 2024, the One Touch Verio Reflect® meter will no longer be available for Insurance Billable purchases and will transition to over-the-counter sales. This change brings some key points to note for both healthcare providers and patients. Impact on Current Stock Availability for Pharmacies Impact on Current Users Available Insurance Billable Meters This transition

Transition of OneTouch Verio Reflect® Meter to Over the Counter Purchases Read More »

Top 10 Pharmacy Interview Questions and How to Answer Them | Expert Advice

Top 10 Pharmacy Interview Questions and How to Answer Them | Expert Advice When aspiring pharmacists prepare for interviews, they often encounter a common set of pharmacy interview questions that can shape the course of their careers. Acing these interview questions not only requires knowledge of medicine and prescriptions but also sharp communication and problem-solving

Top 10 Pharmacy Interview Questions and How to Answer Them | Expert Advice Read More »

Top 10 Crucial Questions to Ask Your Pharmacist Before Taking Medicine

Top 10 Crucial Questions to Ask Your Pharmacist Before Taking Medicine   Before taking any medication, it’s important to engage with your healthcare provider, especially your pharmacist, to ensure that you have a comprehensive understanding of the medication. Asking the right questions can help you make informed decisions about your health and avoid potential risks

Top 10 Crucial Questions to Ask Your Pharmacist Before Taking Medicine Read More »

Patient Education Tips for Amiloride HCL Medication: Important Information to Know

Amiloride is a medication that belongs to a class of drugs called diuretics, specifically known as potassium-sparing diuretics. It works by blocking the action of a specific protein in the kidneys, which helps to increase the excretion of water and sodium from the body while conserving potassium.

Patient Education Tips for Amiloride HCL Medication: Important Information to Know Read More »

What is R-CHOP?

R-CHOP is a chemotherapy regimen commonly used in the treatment of non-Hodgkin lymphoma (NHL), specifically the most common type called diffuse large B-cell lymphoma (DLBCL). R-CHOP stands for: Read moreRegeneron’s Pozelimab-BBFG Receives FDA Approval as First Treatment for CHAPLE DiseaseR – Rituximab: A monoclonal antibody that targets a protein called CD20 found on the surface

What is R-CHOP? Read More »

Cyltezo: Dosage and Cost of the FDA-Approved Interchangeable Biosimilar, adalimumab-adbm to Humira®

Cyltezo: Dosage and Cost of the FDA-Approved Interchangeable Biosimilar, adalimumab-adbm to Humira® Medical advancements have revolutionized the treatment options for various diseases and conditions. In recent years, biosimilars have gained significant attention as cost-effective alternatives to biologic medications. One such biosimilar is Cyltezo, which is an interchangeable biosimilar to Humira®, a commonly used medication for

Cyltezo: Dosage and Cost of the FDA-Approved Interchangeable Biosimilar, adalimumab-adbm to Humira® Read More »

Regeneron’s Pozelimab-BBFG Receives FDA Approval as First Treatment for CHAPLE Disease

The drug Pozelimab can cause life-threatening meningococcal infections, so it is important to get a meningococcal vaccine at least 2 weeks before starting the drug.

It is used to treat a health problem called CD55-deficient protein-losing enteropathy (CHAPLE disease).

Regeneron’s Pozelimab-BBFG Receives FDA Approval as First Treatment for CHAPLE Disease Read More »